GABA B receptors are heterodimeric G proteincoupled receptors composed of R1 and R2 subunits that mediate slow synaptic inhibition in the brain by activating inwardly rectifying K + channels (GIRKs) and inhibiting Ca 2+ channels. We demonstrate here that GABA B receptors are intimately associated with 5 0 AMP-dependent protein kinase (AMPK). AMPK acts as a metabolic sensor that is potently activated by increases in 5 0 AMP concentration that are caused by enhanced metabolic activity, anoxia, or ischemia. AMPK binds the R1 subunit and directly phosphorylates S783 in the R2 subunit to enhance GABA B receptor activation of GIRKs. Phosphorylation of S783 is evident in many brain regions, and is increased dramatically after ischemic injury. Finally, we also reveal that S783 plays a critical role in enhancing neuronal survival after ischemia. Together our results provide evidence of a neuroprotective mechanism, which, under conditions of metabolic stress or after ischemia, increases GABA B receptor function to reduce excitotoxicity and thereby promotes neuronal survival.
GABA B receptors are heterodimeric G proteincoupled receptors composed of R1 and R2 subunits that mediate slow synaptic inhibition in the brain by activating inwardly rectifying K + channels (GIRKs) and inhibiting Ca 2+ channels. We demonstrate here that GABA B receptors are intimately associated with 5 0 AMP-dependent protein kinase (AMPK). AMPK acts as a metabolic sensor that is potently activated by increases in 5 0 AMP concentration that are caused by enhanced metabolic activity, anoxia, or ischemia. AMPK binds the R1 subunit and directly phosphorylates S783 in the R2 subunit to enhance GABA B receptor activation of GIRKs. Phosphorylation of S783 is evident in many brain regions, and is increased dramatically after ischemic injury. Finally, we also reveal that S783 plays a critical role in enhancing neuronal survival after ischemia. Together our results provide evidence of a neuroprotective mechanism, which, under conditions of metabolic stress or after ischemia, increases GABA B receptor function to reduce excitotoxicity and thereby promotes neuronal survival.
INTRODUCTION
GABA B receptors mediate slow prolonged inhibition in the brain by activating postsynaptic inwardly rectifying K + channels (GIRKs) and inactivating presynaptic voltage-gated Ca 2+ channels. GABA B receptors also inhibit adenylate cyclase, leading to diminished activity of PKA signaling pathways (Bowery, 2006) . Structurally, GABA B receptors are members of the class C family of G protein-coupled receptors (GPCRs) and are encoded in vertebrates by two genes, GABA B R1 and GABA B R2, respectively (Bettler et al., 2004; Couve et al., 2004a ). In contrast to the majority of other GPCRs, heterodimerization between GABA B R1 and R2 subunits is required for the formation of functional receptors that reproduce most of the pharmacological and physiological properties of their native counterparts (Bettler et al., 2004; Couve et al., 2004a) . Synaptic activity is critically dependent on cellular energy levels, which are in part determined by the metabolic sensor 5 0 AMP-dependent protein kinase (AMPK). AMPK is rapidly activated when cellular levels of ATP fall coincident with an increase in AMP concentration due to high metabolic activity or the pathological states of anoxia and ischemia (Carling, 2005; Kahn et al., 2005) . AMPK is phosphorylated by the upstream kinases LKB1 on threonine 172 (T172) in a process that is stimulated by AMP. Calmodulin-dependent protein kinase kinase-b (CaMKK) also phosphorylates T172, and phosphorylation of this residue by either of these enzymes enhances AMPK catalytic activity (Hawley et al., 2003 (Hawley et al., , 2005 Woods et al., 2003a; Hurley et al., 2005) . AMPK principally mediates its effect on cellular energy levels by stimulating catabolic metabolism and simultaneously inhibiting anabolic pathways (Kahn et al., 2005) . Accordingly, to date the majority of AMPK substrates identified are either enzymes or transcription factors that control carbohydrate and lipid metabolism (Kahn et al., 2005) .
Here we reveal that AMPK binds directly to GABA B receptors and phosphorylates S783 in the cytoplasmic tail (C-tail) of the R2 subunit, a process that enhances receptor coupling to GIRKs. S783 is basally phosphorylated by AMPK activity in neurons, and mutation of S783 reduces their survival after anoxia. Finally, ischemic injury to the brain produces large increases in S783 phosphorylation within the R2 subunit. In cultured neurons this phosphorylation is important for enhanced neuronal survival after hypoxic insult. Together our results provide evidence of a neuroprotective mechanism in which GABA B receptor function is increased after ischemia to reduce excitotoxicity.
RESULTS

AMPK Binds Directly to GABA B Receptors
To identify signaling molecules that regulate GABA B receptor functional expression, we searched for cytoplasmic binding partners for these proteins. To this end, the C-tail of the GABA B R1 subunit was used as a bait in a two-hybrid screen of a rat brain cDNA library expressed in yeast (Couve et al., 2001; Restituito et al., 2005) . This resulted in the identification of residues 289-550 of the a1 subunit of AMPK as a binding partner for the C-tail of the GABA B R1 subunit, but not for the corresponding domain of R2 (Figures 1A and 1B) . AMPK holoenzyme is ubiquitously expressed in all cell types and is composed of catalytic a1 or a2 subunits together with regulatory b and g subunits. Residues 289-550 of AMPK a1/2 subunits are not required for catalytic activity, but this domain has been suggested to act as a scaffold mediating interaction with b and g subunits (Carling, 2005; Kahn et al., 2005) .
To confirm our observations in yeast, we first used in vitro binding assays. AMPK a1/2 subunits were detected binding to glutathione-S-transferase fusion proteins (GST) encoding the C-tail of the R1 subunit (GST-CR1) (Couve et al., 2001 (Couve et al., , 2004b , but not binding to GST alone, from detergent-solubilized brain extracts (Figure 1C) as measured by immunoblotting with antibodies that recognize the a1/2 subunits of AMPK (Fryer et al., A bait encoding the C-tail of GABA B R1 (CR1) was used to screen a rat brain library, resulting in the identification of clones encoding AMPK a1 subunit. The smallest positive which encoded amino acids 289-550 of the AMPK a1 subunit was retransformed into yeast with empty vector (control), CR1, or CR2. Resulting clones were then tested for b-gal activity; +++ = +ve, ÀÀÀ = Àve. (B) A schematic of the major functional domains within the a1/2 subunits of AMPK. The catalytic domain (red) with the autophosphorylation site T172 and the domains for binding b and g subunits in addition to GABA B receptors (black) are shown. (C) In vitro binding of GST-CR1 and AMPK. Fusion proteins were immobilized on GST-agarose and exposed to detergent-solubilized brain extracts. Bound material was then immunoblotted with an antibody for a1/2 subunits of AMPK. The input lane represents 10% of the material used in each assay. (D) Phosphorylation of GST-CR1 by AMPK from brain lysates. GST-CR1 was exposed to brain lysates and bound material was exposed to 32 Pg-ATP in the presence and absence of 100 mM 5 0 AMP for 10 min at 37 C. Phosphorylation was then assessed by SDS-PAGE (upper panel). The level of 32 P incorporation was measured against controls in the absence of 5 0 AMP (=100%; n = 3). (*) = significantly different from control (p < 0.01; Student's t test).
(E) Immunoprecipitation of AMPK and GABA B receptors from brain extracts. Crude brain membranes were immunoprecipitated with antibodies that recognize the a1/2 subunits of AMPK. Precipitated material was then immunoblotted with antibodies against the GABA B R1 and R2 subunits as indicated. Input represents 10% of the material used for each experiment. (F) Colocalization of AMPK and GABA B receptors in hippocampal neurons at 12-16 DIV. Neurons were fixed, permeabilized, and stained with antibodies against GABA B receptors and AMPK a1/2 subunits with secondary antibodies conjugated to FITC and rhodamine, respectively. Scale bar, 5 mm. (G) An enlargement of the boxed area shown in (F).
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). Using deletion analysis it was evident that residues 910-925 within the coiled-coil domain of the GABA B R1 subunit (Bettler et al., 2004; Couve et al., 2004a) are essential in mediating the binding of CR1 to AMPK (data not shown; Bettler et al., 2004; Couve et al., 2004a) . Bound material was also subjected to in vitro kinase assays. Phosphorylation of GST-CR1 was evident, which could be significantly enhanced by 5 0 AMP ( Figure 1D ). Phosphorylation occurred exclusively on serine residues within a single major phospho-peptide (see Figures S1A and S1B in the Supplemental Data). No phosphorylation of GST alone was seen in these assays, a finding consistent with our previously published studies (Brandon et al., 1999b) . Immunoprecipitation was also used to measure the association of GABA B receptors with AMPK. Both R1 and R2 subunits were detected coimmunoprecipitating with antibodies against the a1/2 subunits of AMPK, but not with control IgG, from detergent-solubilized brain extracts ( Figure 1E ). Finally, we examined the subcellular distribution of AMPK a1/2 subunits and GABA B receptors using immunofluorescence in 10-14 DIV cultured hippocampal neurons. Significantly, AMPK staining was evident in neuronal processes and was also found in the nucleus, consistent with previous studies on the distribution of this multifunctional signaling molecule ( Figure 1F ; Carling, 2005; Kahn et al., 2005) . GABA B receptor immunoreactivity was evident in neuronal cell bodies and processes ( Figure 1F ) as detailed previously in cultured neurons (Couve et al., 2001; Restituito et al., 2005) . Strikingly, colocalization of GABA B receptors with AMPK was evident for receptor populations close to or on the cell surface ( Figure 1G ).
Collectively, our experiments reveal that GABA B receptors can interact directly with AMPK and that these proteins are intimately associated in neurons.
Identification of AMPK-Dependent Phosphorylation Sites within the GABA B Receptors
We used in vitro phosphorylation to further assess the significance of AMPK binding to GABA B receptors. Consistent with our observations from brain extracts ( Figure 1D ), purified AMPK phosphorylated GST-CR1 exclusively on serine residues, while GST alone was not significantly phosphorylated under the same conditions ( Figure 2A ). GST-CR1 was phosphorylated solely on serine residues ( Figure 2B ) within a single major tryptic peptide (Figures S1A and S1B). GST-32 P-CR1 phosphorylated to a stoichiometry of 0.3 mol/mol by AMPK and was then subjected to trypsin digestion, and the resulting peptides were fractionated by HPLC ( Figure S2A ). This revealed that the majority of the radiolabel eluted as a single peak, which was subject to Edman degradation. A single major peptide was found in these fractions (RHQLQSRQQ) which contained a single serine residue corresponding to S917 in CR1 (Figure 2C) . To confirm the identity of this site, we compared the phosphorylation of GST-CR1 and a mutant in which GST-CR1 (R1), GST-CR2 (R2), and GST were phosphorylated in vitro by purified AMPK for 10 min at 30 C. Phosphorylation was then evaluated by autoradiography (upper panels) and Coommassie staining (lower panels).
(B) GST-CR1 and GST-CR2 are phosphorylated on serine residues by AMPK. The migration of phospho-amino acid standards is indicated.
(C) S917 is a major phosphorylation site for AMPK in GST-CR1. A major peptide that contained a single phospho-serine residue corresponding to S917 in the GABA B R1 subunit was identified using HPLC.
(D) Analysis of GST-CR1 phosphorylation using site-specific mutagenesis. GST-CR1 (1), GST-CR1 S917A (2), and GST-CR1 S917/923A (3) were phosphorylated in vitro using purified AMPK in the presence of 100 mM 5 0 AMP for 10 min at 37 C, followed by SDS-PAGE and subjection to autoradiography (upper panels) or Coommassie staining (lower panels). The level of phosphorylation for each mutant was then compared with that seen for GST-CR1, which was given a value of 100%. (*) = significantly different from control (p < 0.01; Student's t test; n = 4). (E) S783 is the major site of phosphorylation for AMPK in GST-CR2. 32 P-GST-CR2 was digested with trypsin and the resulting peptides were separated by HPLC. The level of 32 P in the respective fractions was then quantified. The majority of the recovered counts eluted as a single peak, which was subjected to mass spectroscopy ( Figure S2 ). This revealed the presence of a major peptide that contained a single phospho-serine residue corresponding to S783 in GABA B R2. (F) Analysis of GST-CR2 phosphorylation using site-specific mutagenesis. GST-CR2 (1) and GST-CR2 S783A (2) were phosphorylated in vitro using purified AMPK for 10 min at 37 C, followed by SDS-PAGE and subjection to autoradiography (upper panels) or Coommassie staining (lower panels).
The level of phosphorylation for the S783A mutant was then compared with that seen for GST-CR2, which was given a value of 100%. (*) = significantly different from control (p < 0.01; Student's t test; n = 5).
S917 had been converted to an alanine (GST-CR1
S917A
). Mutation of this residue significantly decreased phosphorylation by AMPK to 70% ± 5.2% of that seen with GST-CR1 ( Figure 2D ; p < 0.01). We next compared the patterns of phosphorylation of GST-32 P-CR1 and GST-32 P-CR1 S917A by tryptic peptide mapping. For GST-32 P-CR1, phosphorylation occurred within a single major peptide that was strikingly similar to that seen in the phosphorylation of GST-CR1 with brain extracts (peptide 1; Figures S1B and S1C). Mutation of S917 eliminated phosphopeptide 1; however, a number of new phospho-peptides became evident, suggesting that mutation of S917 unmasks other AMPK substrates within CR1 ( Figure S1C ). Consistent with this, we found that comutation of S923 with S917 (GST-CR1 S917/923A ) further reduced AMPK phosphorylation to 10% ± 5.5% of the level seen with GST-CR1 ( Figure 2D ; p < 0.01; n = 4) and eliminated the majority of the new phospho-peptides seen with GST-32 P-CR1
. We also analyzed whether the C-tail of GABA B R2 (GST-CR2) is a substrate of AMPK. GST-CR2 was phosphorylated by AMPK ( Figure 2A ) and 32 P-GST-CR2 migrated as a doublet, consistent with the instability of this purified protein as documented previously (Couve et al., 2002) . Phospho-amino acid analysis and peptide mapping revealed that phosphorylation of GST-CR2 occurred exclusively on serine residues within a single major phosphopeptide ( Figure 2B ; Figure S1C ). 32 P-GST-CR2 labeled to a stoichiometry of 0.15 mol/mol by AMPK was digested with trypsin, and the resulting peptides were then subjected to fractionation by HPLC ( Figure 2E ). The majority of the counts eluted as a single peak and was further analyzed by HPLC-tandem mass spectroscopy ( Figure S2 ). Two peptides of 1546.65 Da and 1606.52 Da were detected. Analysis of collision-induced dissociation (CID) spectra revealed that these peptides represented the unphosphorylated peptide TSTSVTSVNQAS 783 TSR derived from the GABA B R2 C-tail, and that the same peptide singly phosphorylated at S 783 ( Figure S2B ). To confirm the identity of S783 as an AMPK substrate, we prepared a mutant form of GST-CR2 in which S783 was converted to an alanine residue (GST-CR2
S783A
). This mutation totally abolished AMPK-dependent phosphorylation of GST-CR2 ( Figure 2F) . Thus, our in vitro studies suggest that GABA B receptors are substrates of AMPK with major phosphorylation sites at S917 and S783 in the C-tails of the R1 and R2 subunits, respectively. Interestingly, neither S917 nor S923 conform to the consensus for phosphorylation by AMPK previously determined by experiments using synthetic peptides (Scott et al., 2002) . Presumably, the intimate association of GABA B receptors with AMPK facilitates the phosphorylation of nonconsensus sites within these receptors.
Phosphorylation of S783 by AMPK Activity Decreases GABA B Receptor Rundown Phosphorylation of the intracellular domains of GPCRs is critical in regulating their function. Therefore, we measured whether the activation of AMPK regulates GABA B receptor effector coupling. To do so we investigated the activation of K + channels by recombinant GABA B receptors using HEK-293 cells stably expressing Kir 3.1 and 3.2 channels (GIRK cells) and transiently expressing R1 and R2 GABA B receptor subunits. We conducted time course studies for membrane currents activated with a submaximal (10 mM) GABA concentration. Consistent with previous studies (Couve et al., 2002) , internal perfusion with a patch pipette electrolyte containing ATP and GTP initiated a time-dependent rundown in the GABAactivated K + current to 33% ± 3% of control after 22 min ( Figure 3A) . Interestingly, inclusion of 1 mM AMP in the patch pipette solution, in the presence of ATP and GTP, partially prevented the rundown of the GABA-activated K + current to 524% ± 4% after 22 min ( Figure 3A ) compared with a patch pipette solution containing just ATP and GTP. The rundown in the GABA B receptor-activated K + currents was described by monoexponential decays, with time constants that appeared independent of the pipette composition and receptor subunit composition ( Figure S3 ). Given that decreasing the ATP:AMP ratio results in the activation of AMPK (Carling 2005; Kahn et al., 2005) , we tested if the effects of AMP on GABA-activated K + currents were dependent upon the AMPK phosphorylation sites S917 and S783 in the C-tails of the R1 and R2 subunits, respectively ( Figure 2 ). GABA concentration response curves for R1 S917A R2, R1/R2
, and wild-type R1/R2 GABA B receptors ( Figure 3B ) revealed that the mutations caused only minor rightward lateral shifts. These shifts were in accord with the 2-to 4-fold reduction in GABA potency compared with that measured on the wild-type receptor. The corresponding GABA concentrations at which half of the maximal effect was seen (EC 50 s) were: R1/R2, 0.3 ± 0.03 mM; R1 S917A R2, 1.2 ± 0.1 mM; and R1/R2 S783A , 0.7 ± 0.1 mM. The stability of the GABA-activated K + currents was also assessed for both of the mutant receptors using a submaximal GABA concentration (10 mM). Cells expressing R1 S917A R2 subunits exhibited significant rundown when dialyzed with ATP and GTP alone (40% ± 2% of control; Figure 3C ). After the addition of 1 mM AMP to the ATP and GTP pipette solution, GABA responses declined to 57% ± 5% after 22 min ( Figure 3C ), which was similar in profile to the rundown noted for the wild-type receptor ( Figure 3A ).
In contrast with wild-type or R1 S917A R2 GABA B receptors, GABA-activated K + currents evoked on R1/R2 S783A displayed a different time course profile when the patch pipette solution was supplemented with 1 mM AMP ( Figure 3D ). Initially, using internal solutions containing ATP and GTP, the current rundowns were quite similar in profile to those recorded with wild-type receptors (ATP and GTP alone; 42% ± 6%; Figure 3D ). However, the addition of AMP to the ATP and GTP internal solution had little effect on the GABA-activated K + current rundown (37% ± 4%; Figure 3D ) compared with ATP and GTP alone. Similar effects of AMP were seen in cells expressing GABA B receptors containing both R1 S917A and R2
(data not shown). These data suggest that S783 in the R2 subunit is responsible for mediating the effects of AMPK activity on GABA B receptor rundown. To ensure that AMP was not having an indirect effect on the GABA-activated K + current via GABA B receptors, an AMPK activator, metformin, was used. Metformin activates the AMPK complex independently of the ATP:AMP ratio inside the cell (Fryer et al., 2002; Hawley et al., 2002; Woollhead et al., 2005) . Time course profiles for 10 mM GABA-activated K + currents were constructed for all three GABA B receptors: R1/R2, R1 These results suggest that the activation of AMPK, by either AMP or metformin, and the subsequent phosphorylation of S783 on the GABA B R2 subunit, were responsible for ameliorating the rundown of GABA-activated K + currents in GIRK cells.
Production of a Phospho-Specific Antibody against S783 in GABA B R2
Our functional studies have illustrated that AMPK modulation of recombinant GABA B receptors is critically reliant upon S783 in the R2 subunit (Figure 3 ), an in vitro substrate of this kinase ( Figure 2 ). To further analyze the phosphorylation of this site, an antiserum was raised against a synthetic peptide chemically phosphorylated on the residue corresponding to S783 (VNQAS-P04TSRL). Affinity purified anti-pS783 recognized GST-CR2 only when the latter had been prephosphorylated by AMPK, which was abolished following preadsorption with the phosphorylated but not dephosphorylated antigen ( Figure 4A ). We further analyzed the specificity of pS783 using recombinant expression GABA B receptors expressed in HEK-293 cells. For these experiments, transfected HEK-293 cells expressing GABA B receptors were labeled with NHS-Biotin. Cell surface receptor populations were purified on immobilized avidin and subjected to immunoblotting. A band of 102 kDa corresponding to the R2 subunit was detected in cells expressing either R2 or R2 S783A subunits using anti-R2 antibodies ( Figure 4B ; Couve et al., 2002 Couve et al., , 2004b . A band of identical size, which was specifically blocked by phosphorylated but not dephosphorylated antigen (Figure 4B) , was evident only in cells expressing R2 subunits. Using R2 antibodies we compared the cell surface expression levels of GABA B receptors incorporating wildtype or R2 S783A subunits, and it was evident that mutation of S783 did not alter cell surface stability of the R2 subunit ( Figure 4D ; 105% ± 9.4% of control; n = 4). The effects of phenformin, a more potent and cell-permeable activator of AMPK than metformin, on S783 phosphorylation were assessed (Fryer et al., 2002; Hawley et al., 2002; Woollhead et al., 2005) . This agent produced a large and highly significant increase in AMPK activity as measured by enhanced phosphorylation of T172 in AMPK a1/2 subunits ( Figure 4E ; Carling 2005; Kahn et al., 2005) . The effects of phenformin on S783 phosphorylation for cell surface GABA B receptors were assessed by immunoblotting of biotinylated cell surface fractions. Phenformin treatment produced a large increase in S783 phosphorylation without modifying R2 cell surface expression levels ( Figure 4E ). In these experiments, which used Triton-soluble extracts, R2 often migrated as a doublet when blotted with anti-p783, which may either reflect degradation upon sample preparation or a specific phosphorylation-dependent shift in mobility of the R2 subunit.
Together these results reveal that S783 is an AMPK substrate, and that the amelioration of GABA B receptor activation of GIRKs in HEK-293 cells (Figure 3 ) was likely to have been mediated by direct phosphorylation of this residue.
S783 Is Phosphorylated in the Brain and in Cultured Neurons
Immunoblotting with anti-pS783 was used to evaluate the phosphorylation of GABA B receptors in brain extracts. This antibody recognized a band of 102 kDa identical to that seen with anti-R2 antibody in membrane fractions prepared from cerebral cortex, hippocampus, and cerebellum, which was abolished by pretreatment with l phosphatase ( Figure 4F ). We further analyzed phosphorylation of GABA B R2 using immunoprecipitation of detergent-solubilized hippocampal membranes followed by immunoblotting. Bands of 102 kDa were seen with both anti-R2 and p783 antibodies immunoprecipitating with R2 antibody, but not with control IgG (Figure 4G ). The R1 subunit was also detected coimmunoprecipitating with AMPK antibody, but not with control IgG ( Figure 4G ).
We next evaluated the phosphorylation of S783 in 10-14 DIV cultured hippocampal neurons that were treated with or without 10 mM phenformin. In agreement with our observations in HEK-293 cells, phenformin produced a significant increase in AMPK activity as measured by immunoblotting of p172 (325% ± 45.2% of control; Figure 4H; p < 0.01, n = 4). To measure the effects on GABA B receptors, neurons were labeled with NHS-Biotin and cell surface proteins were isolated on immobilized avidin and immunoblotted with R2 and pS783 antibodies. This revealed that phenformin significantly enhanced surface receptor S783 phosphorylation to 185% ± 20.2% of control ( Figure 4H ; p < 0.01) without significantly altering total R2 expression levels ( Figure 4H ; 110% ± 11%).
Immunofluorescence was used to further analyze the distribution of phosphorylated GABA B receptors in cultured hippocampal neurons. At 12-14 DIV neurons were fixed, permeabilized, and stained with anti-pS783. This antibody labeled neurons by the soma and neuronal processes and was blocked by the phosphorylated peptide antigen, but not by its nonphosphorylated equivalent ( Figure S4 ). We also compared the distribution of pS783 staining with that for total R2 subunits using double immunofluorescence. Immunoreactivity for pS783 and R2 was evident in the cell bodies and neuronal processes of cultured hippocampal neurons ( Figure 4I) . We compared the colocalization of cR2 and p783 immunofluorescent puncta for pS783 and R2 on neuronal processes. 84.74% ± 10.2% (n = 4) of pS783 puncta also contained immunoreactivity for R2. In contrast, only 25% ± 4.5% (n = 5) of R2 puncta contained immunoreactivity for pS783. This discrepancy most likely reflects the fact that not all GABA B receptors containing R2 subunits are phosphorylated on S783; consistent with this, treatment of cultured neurons with the AMPK activator metformin robustly increased phosphorylation of this residue ( Figure 4H ).
Together these biochemical studies demonstrate that GABA B receptors in both the brain and cultured neurons are phosphorylated on S783 in the R2 subunit, and strongly suggest a role for AMPK activity in regulating the phosphorylation of this residue.
Phosphorylation of S783 in Hippocampal Neurons
Is Dependent upon AMPK Activity Given the paucity of specific AMPK inhibitors, we used a genetic approach to further elucidate the role of this kinase in regulating GABA B receptor phosphorylation. To do so we utilized a dominant-negative a1 subunit expression construct in which aspartate 157 had been mutated to an alanine residue and modified with a myc epitope (DNa1; Woods et al., 2000) . This construct is catalytically inactive but can still assemble with kinase b and g subunits and has been used to inhibit AMPK activity in many experimental systems (Carling, 2005; Kahn et al., 2005) . Twelveto twelve-day-in-vitro hippocampal neurons were transfected with a plasmid encoding DNa1, and effects on GABA B receptor phosphorylation were then evaluated 24-48 hr later using triple immunofluorescence and high-resolution confocal microscopy. In neurons expressing DNa1, as revealed by high levels of myc staining, there appeared to be a reduction in S783 fluorescence compared with that of nontransfected neurons, while the levels of R2 staining appeared similar ( Figure 5A and 5B). To quantify these results we compared the number of R2 puncta containing pS783 immunoreactivity (R2/p783 colocalization) with data being normalized to values seen in control neurons (=100%). The number of R2 puncta containing p783 immunoreactivity in DNa1-expressing neurons identified via their myc fluorescence decreased significantly to 21% ± 4.5% of the level seen in control nonexpressing neurons ( Figure 6A) . To control for possible nonspecific effects of DNa1 expression, we analyzed the level of phosphorylation of S892, a substrate of PKA, using another phospho-specific antibody against this site (antipS892; Couve et al., 2002) . In both control neurons and those expressing DNa1, very similar levels of colocalization between pS892 and R2 staining were evident ( Figures  5C and 5D and Figure 6A ). As a final control we assessed the effects of expressing GFP on the phosphorylation of both S783 and S892, which revealed that expression of this protein did not alter the levels of either S783 or S892 phosphorylation ( Figure 6A ). Together these results in hippocampal neurons demonstrate that overexpression of a dominant-negative AMPK catalytic subunit can specifically decrease S783 phosphorylation, strongly suggesting that basal phosphorylation of this site is dependent upon AMPK activity.
AMPK Modulates GABA B Receptor Function in Hippocampal Neurons
As neuronal AMPK was capable of phosphorylating GABA B receptors, we next determined whether such phosphorylation could affect native GABA B receptor function. We utilized different patch pipette solutions while making whole-cell recordings from cultured hippocampal neurons at 7-14 DIV and employed baclofen as the GABA B agonist to avoid the activation of native GABA A receptors. As noted previously in HEK-293 cells expressing recombinant GABA B receptors, the activation of K + current by 10 mM baclofen exhibited significant rundown to 50% ± 5% of the level observed at zero time when dialyzed with electrolyte containing ATP and GTP (Figure 7B) . To assess the role of AMPK in modulation of GABA B receptor function, metformin (10 mM) was added to the patch pipette solution (with ATP and GTP) to directly activate AMPK without altering the intracellular ATP:AMP ratio. Metformin significantly reduced rundown to 68% ± 11% of the level seen at zero time ( Figure 7B ; p < 0.01, n = 4-12 cells). Overall, these data suggest that the activation of AMPK, and hence phosphorylation of S783 in neurons, can maintain the stability of baclofen-activated K + currents.
S783 Phosphorylation in the Hippocampus Is Enhanced by Ischemic Brain Injury
Anoxia and ischemia lead to rapid activation of AMPK (Carling, 2004; Kahn et al., 2005; Gadalla et al., 2004; McCullough et al., 2005; Ramamurthy and Ronnett, 2006) . We therefore sought to test whether ischemic brain injury after transient occlusion of the middle cerebral artery occlusion (MCAO) modifies GABA B phosphorylation in rats (Belayev et al., 1996; Longa et al., 1989) . After injury 
Receptor Phosphorylation in Hippocampal Neurons
Twelve-to fourteen-day-in-vitro cultured hippocampal neurons were transfected with a plasmid encoding myc-tagged DNa1. Twenty-four to forty-eight hours after transfection, neurons were fixed, permeabilized, and stained with antibodies specific for GABA B R2 subunits (secondary antibody conjugated to rhodamine) and specific for myc (secondary antibody conjugated to FITC). Neurons were also stained with anti-pS783 antibodies (A-B) or pS892 (C-D) conjugated to Alexa 405. Images were recorded from both untransfected neurons (A and C) and those expressing DNa1 (B and D) using the same microscope settings. Scale bars, 5 mm.
rats were allowed to recover for 80 min before perfusion with 4% paraformaldehyde. It is well established MCAO produces a specific hemispheric injury (Belayev et al., 1996; Longa et al., 1989) . To detect the location of the infarct in our experiments, coronal brain sections from treated and untreated animals were first stained with anti-pS783 and then with secondary antibodies conjugated to HRP before visualization with DAB followed by microscopy. In the animal shown in Figure 7A , the area of ischemic damage (+) was localized to the left-hand side of the brain, as measured by the drastic loss of pS783 staining in a large infarct that centered on the caudate/putamen. In contrast the right side of the brain [ Figure 7A (À)] remained undamaged and was similar to the same brain regions from control animals ( Figure 7B ). After identifying the area of brain injury, we proceeded to examine S783 phosphorylation in the hippocampus for comparison with our studies in cultured neurons. Strikingly, enhanced immunoreactivity in the CA3 and dentate gyrus (DG) was seen for the pS783 antibody only in the injured side of the brain ( Figures 7C, 7E , and 7G, black box), while the uninjured side of the brain ( Figures 7C, 7F , and 7H, red box) exhibited levels of staining similar to those of control animals ( Figure 7D ). However, the levels of pS892 and R2 staining appeared unaltered in both the ischemic and uninjured sides of the brain ( Figure 7I and 7J ).
To further analyze the level of GABA B receptor phosphorylation in these experiments, we directly compared optical density measurements of immunoreactivity between the varying regions of injured and control hippocampi and the corresponding areas of untreated animals using MetaMorph analysis. This revealed that ischemic injury produced large and highly significant increases in S783 phosphorylation within the CA3 and DG areas while the levels of R2 subunit immunoreactivity remained unaltered ( Figure S4 ). To examine the subcellular sites of S783 phosphorylation, we stained hippocampal sections from ischemic brain with antibodies against p783 and parvalbumin, a marker for some interneurons (Celio, 1990) . Immunofluorescent images were then collected by confocal microscopy, revealing that p783 staining was found in parvalbumin-positive interneurons ( Figure 8A ). Strong p783 immunoreactivity was also evident in distinct puncta within the pyramidal layer of CA3 ( Figure 8A ). These results demonstrate that S783 is phosphorylated in GABAergic interneurons and strongly suggest that this site is also phosphorylated in glutamatergic pyramidal neurons.
S783 Promotes Neuronal Survival after Chemical Anoxia
To further analyze the role of S783 in ischemia, we used cultured hippocampal neurons (10-14 DIV) and evaluated whether transient anoxic insult (10 mM deoxyglucose and 10 mM azide; Imura et al., 1999; Kume et al., 2002) would activate AMPK and enhance GABA B receptor phosphorylation. In agreement with our studies in whole animals, anoxic insult significantly increased the phosphorylation of S783 in GABA B receptors and T172 in AMPK. 180 min after anoxia, their phosphorylation increased by 330.20% ± 32% and 350.40% ± 45%, respectively (p < 0.01), without significantly altering the total cellular levels of these proteins ( Figure 8B ). We next evaluated the effects overexpressing FLAGtagged GABA B R2 F or R2 FS783A subunits (Couve et al., 2002) on the survival of cultured neurons after anoxia.
For these experiments we utilized nucleofection to express these differing transgenes in cultured neurons, a technique previously established to produce transfection efficiencies of approximately 35% (Kittler et al., 2004; Couve et al., 2004b) . To assess transgene expression, 10-14 DIV nucleofected neurons were immunoblotted with FLAG antibodies. This revealed the expression of bands of 102 kDa in neurons nucelofected with GABA B R2 F or R2 FS783A subunits, but not in control cultures ( Figure 8C ). Significantly, expression of recombinant R2 subunits did not alter the overall expression levels of these proteins in nucleofected neurons or the levels of AMPK a1/2 subunits ( Figure 8C ). To measure the effect of S783 on survival, expressing neurons were exposed to a 15 min anoxic insult, cultured for a further 15 hr, and stained with trypan blue to assess viability ( Figure 8D ). This analysis revealed that survival for neurons expressing wild-type GABA B R2 F was 60.20% ± 2.3%, while survival for neurons expressing R2
FS783A subunits was significantly reduced by 11.08% to 49.12% ± 2.2% (p < 0.01).
After controlling for the efficiency of nucleofection, mutation of S783 decreases neuronal survival by approximately 31% after ischemia. Together these in vitro observations provide the first direct evidence that we know of that S783 can modulate neuronal survival after anoxic injury.
DISCUSSION
GABA B receptors are critical heterodimeric GPCRs which are important for the induction of slow and prolonged synaptic inhibition in the brain (Bowery, 2006) . However, what has remained largely enigmatic is whether other signal transduction pathways are capable of exerting long-term regulation over GABA B receptor function. Here we reveal that functional heteromeric GABA B receptors composed of R1/R2 subunits directly bind to, and are phosphorylated by, AMPK, which then influences their function. The identification of S783 on the R2 subunit as an AMPK substrate has subsequently allowed us to reveal a link between the induction of ischemia and increased phosphorylation of GABA B receptors in the hippocampus. During ischemia intracellular ATP levels decrease and Ca 2+ levels increase (Choi, 1998) , which leads to the activation of kinases upstream of AMPK, including LKB1 and CaMKK (Hawley et al., 2005; Hurley et al., 2005; Woods et al., 2003a; 2003b) . This increase in GABA B receptor phosphorylation, evident during ischemia, is predicted to enhance receptor effector coupling and provides a new and potentially neuroprotective mechanism that may limit neuronal exposure to excitotoxicity. GABA B Receptors as Substrates for AMPK By using yeast two-hybrid screens, in vitro binding/kinase assays, immunoprecipitation, and immunofluorescence assays, it is clear that the interaction of GABA B receptors and AMPK is mediated initially by the direct binding of the kinase a1/2 subunits to the C-tail of the GABA B R1 subunit. Interestingly, AMPK phosphorylated the C-tails of both the GABA B R1 and R2 subunits in vitro, and this phosphorylation occurred exclusively on serine residues. We subsequently identified two major sites of AMPK phosphorylation: S917 and S783 in the C-tails of GABA B R1 and R2 subunits, respectively.
Functional Modulation of GABA B Receptors by AMPK
A number of binding partners for GABA B receptors have been identified to date, including 14-3-3 isoforms, ATF4/ CREB2, and Marlin-1, but the precise role that these binding partners play in regulating GABA B receptor functional expression remains to be determined (Couve et al., 2004a) . While AMPK has been established as an important regulator of the cellular levels of ATP via inhibition of anabolic metabolism and activation catabolic pathways (Carling, 2004; Kahn et al., 2005) , our results now suggest a role for this kinase in modulating inhibitory neurotransmitter receptors. Using patch-clamp recording, the coupling of GABA B receptors to GIRKs in HEK-293 cells typically exhibited significant levels of rundown when activated by GABA, despite the internal solution containing ATP and GTP. When this was supplemented by AMP or metformin, rundown was substantially ameliorated, suggesting that the activation of AMPK was instrumental in this modulation. By using mutagenesis we were able to determine whether both GABA B receptor subunits needed to be phosphorylated for AMPK to regulate receptor function. From this approach it was evident that the functional effects of AMPK were mediated via S783 on R2, rather than S917 on R1. We therefore proposed that the C-tail of the R1 subunit was more likely to mediate the binding of AMPK to GABA B receptors rather than transduce any functional effect. Consistent with this role for R2, we have demonstrated that phosphorylation of this subunit by PKA on S892 also alleviates GABA B receptor rundown by enhancing its activation of GIRK channels (Fairfax et al., 2004; Couve et al., 2002) .
Direct Phosphorylation of Neuronal GABA B Receptors
To directly measure the phosphorylation of S783, we raised a phospho-specific antibody against this residue. Using pS783 we were able to confirm that this residue was basally phosphorylated in HEK-293 cells, rat brain membranes, and cultured hippocampal neurons. The level of phosphorylation of S783 was significantly enhanced after AMPK activation with phenformin. Phosphorylation of S783 did not modify the cell surface expression levels of GABA B receptors in these various cell systems. This supports a number of studies showing that neuronal GABA B receptors do not undergo agonist-or PKA-induced internalization (Couve et al., 2004a) . To directly evaluate S783 phosphorylation in neurons, we employed a dominant-negative a1 AMPK subunit construct because specific inhibitors for this kinase do not exist. In neurons expressing DNa1, a large decrease in the phosphorylation of S783 was evident. However, phosphorylation of S892, a residue predicted to be adjacent to S783 in GABA B R2 and previously identified as a PKA substrate, remained unaltered. These results demonstrate that neuronal GABA B receptors are indeed phosphorylated on S783 and that AMPK activity plays a critical role in regulating the phosphorylation of this residue. To examine the functional consequences of AMPK phosphorylation on the activity of neuronal GABA B receptors, electrophysiological analyses were utilized. In agreement with our recombinant data, the activation of GIRK channels by GABA B receptors again exhibited rundown under control conditions. This rundown was largely abrogated using a patch pipette solution supplemented with metformin. These results provide strong evidence of a role for AMPK activity in regulating GABA B receptor effector coupling in neurons.
Modulation of AMPK after Ischemic Insult
Given the critical role AMPK activity plays in conserving cellular levels of ATP, we considered that its ability to enhance GABA B receptor functional coupling may be significant under conditions of metabolic stress. This type of stress could be imposed on a cell by persistent neuronal depolarization, or alternatively, it can manifest during anoxic or ischemic injury; all of which are conditions known to decrease cellular levels of ATP or increase Ca 2+ levels and lead to the robust activation of AMPK (Carling, 2004; Kahn et al., 2005; Gadalla et al., 2004; McCullough et al., 2005; Ramamurthy and Ronnett, 2006) . To test our hypothesis we analyzed the phosphorylation of GABA B receptors after ischemic injury to the brain induced by MCAO. This insult revealed a large increase in the phosphorylation of S783 in CA3 and DG, but not in the CA2 regions of the hippocampus. In contrast, the phosphorylation of S892 in GABA B R2 remained unaltered, as did the overall expression levels of R2.
To provide further insight into the possible role of S783 phosphorylation in ischemia, we examined the effects of anoxia on cultured hippocampal neurons. Anoxia significantly increased AMPK activity and enhanced phosphorylation of S783, consistent with our studies in whole animals. Moreover, using overexpression of R2, we established that mutating S783 significantly decreased neuronal survival compared with neurons expressing wild-type GABA B R2 subunits. Thus, our in vivo and in vitro results suggest that ischemic/anoxic injury leads to an increased phosphorylation of S783, which increases GABA B receptor activation of postsynaptic GIRK channels, leading to increased membrane conductance and thereby limiting neuronal activity. If such an effect was also manifested presynaptically, then we would predict that AMPK should also increase the inactivation of Ca 2+ channels via GABA B receptor activation, leading to decreased release of glutamate, GABA, and a range of other neurotransmitters, which may have varying effects on neuronal survival.
However, it is interesting to note that GABA B receptor agonists are neuroprotective in animal models of ischemia, further highlighting a predominant role for these receptors in limiting neuronal activity after ischemic/anoxic injury (Kulinskii and Mikhel'son, 2000; Dave et al., 2005; Jackson-Friedman et al., 1997) . Finally, and in agreement with these whole animal studies, we were able to establish that phosphorylation of S783 appears to play a neuroprotective role in cultured neurons after anoxia.
In conclusion, we have uncovered a role for AMPK in binding to and phosphorylating GABA B receptors, a process which enhances their functional coupling to K + channels. Given that AMPK has a unique ability to respond to decreased cellular levels of ATP, this mechanism, which relies on a single phosphorylatable serine residue in the R2 subunit, may act to decrease synaptic activity under conditions of intense metabolic stress or ischemic injury to conserve cellular energy levels in addition to limiting neuronal injury via excitotoxicity.
EXPERIMENTAL PROCEDURES
Antibodies
Rabbit antibodies against p172 in AMPK were purchased from Cell Signaling Systems. Rabbit polyclonal antibodies against the a1/2 subunits have been detailed previously (Fryer et al., 2002) . Anti-pS783 was raised in rabbits against the synthetic peptide VNQApSTSRL, and the resulting antisera was sequentially purified on dephospho-and phospho-antigens (PhosphoSolutions, Aurora, CO). Anti-pS892 in GABA B R2 (UCL-72) was used as described previously (Couve et al., 2002) . Antibodies were raised against GST-fusion proteins encoding the C-tails of GABA B R1 and R2 in both guinea pigs and chickens. Sera were affinity purified on immobilized antigens before use as outlined previously Couve et al., 2001 ).
Cell Culture and Transfection
Hippocampal cultures were prepared as described previously (Couve et al., 2002 (Couve et al., , 2004b . Ten-to twelve-day-in-vitro hippocampal neurons were transfected using Effectene (Qiagen, Valencia, CA; Jacob et al., 2005) . HEK-293 cells expressing Kir 3.1 and 3.2 channels (GIRK cells; Leaney et al., 2000) were transfected by calcium phosphate using 1:5:1 ratios of GABA B R1, R2, and GFP constructs, respectively (Couve et al., 2002) .
Neuronal Transfection and Anoxia
Dissociated E18 hippocampal neurons were transfected with 3 mg of CMV based expression constructs encoding N-terminally FLAGtagged R2 F (Couve et al., 2002) or R2 FS783A using 3 mg of DNA per 5 3 10 6 neurons using the Rat NucleofectorÔ kit (Amaxa). Cells were used after 10-15 DIV (Couve et al., 2004b; Kittler et al., 2004; Jacob et al., 2005) . For anoxia, neurons were exposed to media containing 10 mM Na + azide and 1 mM glucose for 5 min at 37 C.
Neurons were then re-fed with conditioned media and cultured for a further 24 hr. To measure neuronal survival after this time period, live neurons were stained with trypan blue, then washed extensively before chilling on ice prior to immunohistochemistry with FLAG antibody. Neurons were then fixed and the number of FLAG-positive surviving neurons (trypan blue negative) was calculated for each expression construct.
Expression Constructs
Expression constructs encoding the rat GABA B R1 and R2 subunits modified with N-terminal extracellular FLAG epitopes, GFP, GST-R1
and GST-R2 fusions, and myc-tagged DNa1 expression constructs have all been described previously (Couve et al., 2001; Woods et al., 2000) .
GST Affinity Purification Assays GST-fusion proteins encoding the C-tails of GABA B R1 subunits were expressed and purified as outlined previously (Couve et al., 2001 (Couve et al., , 2004b . For affinity purification GST-fusion proteins were immobilized on agarose and exposed to crude brain membranes solubilized in a buffer containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris (pH 7.6), 5 mM EGTA, 5 mM EDTA, 50 mM NaF, 1 mM Na orthovanadate, 100 mM PMSF, and 10 mg/ml leupeptin, pepstatin, antipain, and aprotinin. After extensive washing in a buffer supplemented with 0.5M NaCl, bound material was subjected to immunoblotting. Bound material was also subjected to in vitro kinase assays in a buffer containing 10 mM Tris (pH 7.5), 10 mM MgCl 2 , and 5 mCi 32 Pg-ATP with or without 100 mM 5 0 AMP for 10 min at 37 C followed by SDS-PAGE (Brandon et al., 1999a (Brandon et al., , 1999b .
Immunoprecipitation Crude brain membranes were solubilized in a buffer containing 2% CHAPS, 150 mM NaCl, 50 mM Tris (pH 7.6), 5 mM EGTA, 5 mM EDTA, 50 mM NaF, 10 mM Na pyrophosphate, 1 mM Na orthovanadate, 10 mM PMSF, and 10 mg/ml leupeptin, pepstatin, antipain, and aprotinin. Lysates were then subjected to immunoprecipitation with antibodies immobilized on protein A sepharose (Couve et al., 2002) , and precipitated material was then subjected to SDS-PAGE followed by immunoblotting with antibodies against GABA B receptors or AMPK.
Immunoblot Analysis and Biotinylation
Cell surface biotinylation of neurons using NHS-Biotin and subsequent immunoblotting with GABA B antibodies using [ 125 I]-coupled anti-rabbit
IgG and quantified using a phospho-imager was performed as detailed previously (Couve et al., 2004b; Fairfax et al., 2004) .
Immunofluorescence
Hippocampal neurons were processed for immunohistochemistry under both permeabilized (+ 0.05% Triton X-100) and nonpermeabilized conditions using the following primary antibodies: Anti-pS892 1:1000; Anti-pS783 1:500; anti-R1 1:1000; and anti-R2 1:5000 (Couve et al., 2002) . Images were then collected on a Bio-Rad Radiance II microscope. All channels were first background subtracted and the threshold value was determined for each culture and used for all images from that culture. Quantification of fluorescence levels was performed on neuronal processes extending from the cell body in the plane of focus. Pixel intensity was then determined and measured in 2-3 mm 2 areas of interest using MetaMorph software (Universal Imaging).
Immunohistochemistry
Animals were deeply anesthetized and intracardially perfused with saline solution followed by 4% paraformaldehyde. Brains were removed, post-fixed overnight, and cryoprotected in 30% sucrose. Free-floating sections were cut at 40 mm using a freezing microtome and stored at À20 C in cryoprotective solution (30% sucrose, 30% ethylenglycol, 1% polyvinylpyrrolidone in PBS) until processing. Sections were washed in PBS and incubated for 10 min in 0.1% H 2 O 2 to block endogenous peroxidase activity. After washing in PBS sections were incubated for 2 hr in blocking solution (2% normal horse serum, 0.5% BSA, and 0.3% Triton X-100 in PBS) followed by incubation for 48 hr at 4 C in blocking solution containing the primary antibody. After rinsing in PBS sections were incubated in blocking solution containing biotinylated anti-rabbit or guinea pig antibody for 2 hr at room temperature, then rinsed in PBS and incubated for 1 hr in ABC solution (Vectastain Elite ABC kit, Vectorlabs). After washing, sections were incubated for 10 min in diaminobenzidine (peroxidase substrate) containing nickel chloride as an enhancing reagent. The reaction was terminated by washing twice in water. Sections were mounted onto slides, air-dried, dehydrated through graded alcohols followed by xylenes, and then mounted for viewing. Sections were visualized with an Olympus BX51 microscope (Olympus Optical) and the optical density was obtained using MetaMorph software (Universal Imaging Corporation).
In Vitro Phosphorylation, Peptide Mapping, and Phospho-Amino Acid Analysis GST-fusion proteins were phosphorylated in vitro using 100-1000 U of AMPK in the presence or absence of 100 mM 5 0 AMP using 5-50 mCi of 32 Pg-ATP and a final ATP concentration of 50 mM for 30 min at 30 C.
Purified AMPK was purchased from Upstate Biotechnology (Lake Placid, NY) and had an activity in excess of 4000 U/mg in the presence of 100 mM 5 0 AMP. Phosphorylation was then assessed by autoradiography and quantified using a phospho-imager. Tryptic peptide mapping and phospho-amino acid analysis were performed as described previously (Brandon et al., 1999a) .
Off-Line HPLC and On-Line HPLC-Tandem Mass Spectrometry In parallel with samples used for TLC tryptic mapping, digests of in vitro GST-CR2 fusion proteins were analyzed using capillary RP-HPLC. Radiolabeled samples (estimated 5 pmol peptides) were loaded on a 150 mm 3 10 cm Microsil C8 column (Ultra-Plus II Micro LC, Micro-Tech Scientific) and 5 min fractions were collected with a robotic microfraction collector (Probot, Dionex). Fraction samples were spotted and quantitated using a phospho-imager (Typhoon, Molecular Dynamics). In parallel, in vitro digests and off-line fractionation was performed using fusion proteins phosphorylated in the absence of 32 P. Digests of these nonradioactive samples (1 ml, estimated 1 pmol peptides) were analyzed by nanoflow reverse phase liquid chromatography (Ultimate LC Packings, Dionex) coupled on-line to a quadrupoleorthogonal time-of-flight tandem mass spectrometer (MS) (QSTAR XL, Applied Biosystems/MDS Sciex) using methods described previously (Huang et al., 2001 ). The QSTAR MS was first operated in an information-dependent mode in which each full MS scan (1 s acquisition) was followed by MS/MS scan (3 s acquisition for MS/MS scan), where the most abundant peptide molecular ions were dynamically selected for low energy CID. Tandem MS/MS spectra were analyzed using both Mascot and a development version of Protein Prospector (Huang et al., 2001 ).
Patch Clamp Electrophysiology
Membrane currents were recorded from single GIRK cells using the whole-cell patch-clamp configuration in conjunction with an Axopatch 1-C amplifier. Patch pipettes (resistances 3-5 MU) were pulled from thin-walled borosilicate glass and filled with a solution containing 120 mM KCl, 2 mM MgCl 2 , 11 mM EGTA, 30 mM KOH, 10 mM HEPES, 1 mM CaCl 2 , 1 mM guanine triphosphate, and 2 mM adenosine triphosphate, with the addition of components as listed in the text, which include 14 mM creatine phosphate, 1 mM adenosine monophosphate, 1 mM metformin, or 1.25 U/ml AMPK (Upstate cell signaling solutions, NY) (pH 7.0). The cells were continuously perfused with Krebs solution containing 140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 11 mM glucose, and 5 mM HEPES (pH 7.4). Before application of GABA or baclofen, the K + concentration of the Krebs solution was increased to 25 mM and the Na + concentration was reduced to 120 mM.
Cells were recorded from 20-48 hr after transfection. Membrane currents were filtered at 5 kHz (À3 dB, 6 th pole Bessel, 36 dB/octave) and stored onto a Dell Pentium III computer for later analysis with Clampex 8. Any change of more than 10% in the resting membrane input conductance or series resistance resulted in the recording being discarded. Peak amplitude GABA-activated K + currents were determined at À70 mV holding potential. Drugs and solutions were rapidly applied to the cells using a modified Y-tube positioned approximately 300 mm from the recorded cell. To construct concentration-response relationships for GABA, the current (I) was measured in the presence of each concentration of GABA applied at 3 min intervals. The currents were normalized to the maximum GABA response (I max ) and the concentration response relationship was fitted with the Hill equation:
where the EC 50 represents the concentration of GABA ([A]) inducing 50% of the maximal K + current evoked by a saturating concentration of GABA, and n H is the Hill coefficient. For the analysis of current rundown, GABA-or baclofen-activated current amplitudes were measured at 3 min intervals, and the resulting time stability relationships were fitted with a monoexponential function of the form:
Àðt=tÞ where y is the GABA/baclofen current amplitude at time t, y o is the residual amplitude at the end of drug application, A represents the amplitude, and t is the decay time constant. The fit was determined using a Marquadt nonlinear least squares routine.
Yeast Two-Hybrid Screens Yeast two-hybrid screens were performed as described previously (Restituito et al., 2005) . The bait plasmid containing the sequence corresponding to the C-tails of GABA B R1 (pMW101-CR1) was used to screen a rat brain cDNA library in yeast vector pJG4-5. Potential interactions were analyzed by growth on plates lacking leucine, uracil, tryptophan, and histidine and confirmed by galactose-dependency and b-galactosidase assays. All positive interactions were confirmed by retransformation into the EGY48 strain and were also confirmed with empty vector and bait encoding the C-tail of the R2 subunit.
Transient Middle Cerebral Artery Occlusion Surgery
Adult male Wistar rats (290-310 g) were anesthetized with 3% isoflurane in 70% nitrous oxide and 30% oxygen through a nose cone.
Temperature was maintained at 37 C throughout the surgery using a heating lamp. Transient MCAO was induced for 90 min using the intraluminal suture method (Longa et al., 1989) . Briefly, an 18 mm length of 4-0 monofilament nylon suture coated with poly-L-lysine (Belayev et al., 1996) and bearing a flame-rounded tip was inserted into the external carotid artery and advanced through the internal carotid to occlude the origin of the middle cerebral artery (MCA). Ninety minutes later the rats were reanesthetized and the suture was withdrawn to allow for reperfusion of cerebral blood flow. Sham operated controls were subjected to the same surgery but without advancement of the suture into the MCA. Two hours following reperfusion, rats were deeply anesthetized and perfused transcardially with 50 ml of saline followed by 200 ml of freshly made 4% paraformaldehyde in PBS. Brains were extracted and post-fixed for 2 hr in 4% paraformaldehyde, then processed for immunohistochemistry.
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